Is Brainstorm Cell Therapeutics Inc. (BCLI) a Buy, Sell, or Hold?
OTC : BCLI
Brainstorm Cell Therapeutics Inc.
$0.97 USD
$0.01 (1.04%)
- Volume
- 6.96K
- Average Volume
- 17.64K
- Market Capitalization
- $10.7M
- P/E Ratio
- -1.03
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.69
- Year Low
- $0.46
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.02
BCLI vs. The Competition
| Properties | BCLI | ACXP | ADIL | ADXN |
|---|---|---|---|---|
| Market Cap | $10.7M | $2.77M | $2.61M | $4.45M |
| Shares Outstanding | $11.03M | $1.58M | $959.64K | $720.25K |
| P/E Ratio | -1.03 | -0.36 | -0.28 | -0.76 |
| EPS | -0.87 | -5.0 | -5.67 | -4.88 |
| Day Low | 0.91 | 1.64 | 2.72 | 5.92 |
| Day high | 0.98 | 1.88 | 2.77 | 6.185 |
| Year Low | 0.46 | 1.326 | 1.31 | 5.41 |
| Year High | 1.69 | 9.96 | 19 | 12.05 |
| Average Price 50 | 0.8462 | 1.7416 | 2.3138 | 6.3901 |
| Average Price 200 | 0.7212 | 3.1848 | 4.5489 | 7.46087 |
| Volume | 6963 | 213.23K | 4078.09 | 2558 |
| Average Volume | - | - | - | - |